Intra-Cellular Therapies, Inc.

UBS Group AG

Report date

3/31/2025

Quarter

2025 Q1

Filed

5/13/2025

Shares

1,590,345

Value ($000)

209,798

Weight

0.0%

2019 Q4 - 2025 Q1 (22 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q1	5/13/2025	209,798	0.0%	1,590,345	3/31/2025
2024 Q4	2/14/2025	6,136	0.0%	73,469	12/31/2024
2024 Q3	11/14/2024	4,113	0.0%	56,211	9/30/2024
2024 Q2	8/14/2024	3,226	0.0%	47,104	6/30/2024
2024 Q1	5/13/2024	9,480	0.0%	136,996	3/31/2024
2023 Q4	2/9/2024	9,652	0.0%	134,762	12/31/2023
2023 Q3	11/9/2023	2,300	0.0%	44,145	9/30/2023
2023 Q2	8/11/2023	4,730	0.0%	74,698	6/30/2023
2023 Q1	5/12/2023	2,154	0.0%	39,774	3/31/2023
2022 Q4	2/8/2023	1,532	0.0%	28,955	12/31/2022
2022 Q3	11/10/2022	121	0.0%	2,606	9/30/2022
2022 Q2	8/10/2022	203	0.0%	3,549	6/30/2022
2022 Q1	5/16/2022	3,746	0.0%	61,220	3/31/2022
2021 Q4	2/14/2022	2,116	0.0%	40,448	12/31/2021
2021 Q3	11/15/2021	125	0.0%	3,350	9/30/2021
2021 Q2	8/13/2021	529	0.0%	12,958	6/30/2021
2021 Q1	5/12/2021	661	0.0%	19,462	3/31/2021
2020 Q4	2/11/2021	622	0.0%	19,586	12/31/2020
2020 Q3	11/12/2020	108	0.0%	4,200	9/30/2020
2020 Q2	7/31/2020	518	0.0%	20,201	6/30/2020
2020 Q1	5/1/2020	768	0.0%	49,995	3/31/2020
2019 Q4	2/14/2020	2,492	0.0%	72,617	12/31/2019